Why the study?
Does catheter-based renal denervation reduce atrial arrhythmogenesis in atrial fibrillation patients with hypertension, heart failure, and sleep apnea?
Does catheter-based renal denervation reduce atrial arrhythmogenesis in atrial fibrillation patients with hypertension, heart failure, and sleep apnea?
Renal denervation may offer potential anti-remodeling effects and reduce arrhythmogenic mechanisms in patients with atrial fibrillation and comorbidities like hypertension, heart failure, and sleep apnea.
Answers are grounded in this paper and cite their sources.
Does not support routine use in AF; leaves open anti-arrhythmic effects pending randomized trials.
Atrial fibrillation is the most common sustained arrhythmia and is associated with significant morbidity and mortality. In addition to mechanisms such as atrial stretch and atrial remodeling, the activity of the autonomic nervous system has also been suggested to contribute to the progression from paroxysmal to persistent atrial fibrillation. Catheter-based renal denervation was introduced as a minimally invasive approach to reduce renal and whole body sympathetic activation with accompanying blood pressure reduction and left-ventricular morphological and functional improvement in drug-resistant hypertension. This review focuses on the potential effects of renal denervation on different arrhythmogenic mechanisms in the atrium and discusses potential anti-remodeling effects in atrial fibrillation patients with hypertension, heart failure and sleep apnea.
No takes yet. Share an insight, caveat, or question.
Linz et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: